Antibodies to Programmed Cell Death Protein 1 That Are PD-1 Agonists
Copyright © Targeted News Service 2024
2024-12-17
ALEXANDRIA, Virginia, Dec. 17 -- GEORGIAMUNE INC., Gaithersburg, Maryland has been assigned a patent (No. US 12168687 B2, initially filed Jan. 26, 2024) developed by Mikayel Mkrtichyan, Tujunga, California, and Samir Khleif, Bethesda, Maryland, for "Antibodies to programmed cell death protein 1 that are PD-1 agonists." . . .